![ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology | Business Wire ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology | Business Wire](https://mms.businesswire.com/media/20231219536657/en/1974123/23/ImpriMed_Logo_Small_500x500.jpg)
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology | Business Wire
Chris Hagenbuch on LinkedIn: ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary…
![Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet](https://connected-vet.com/wp-content/uploads/2024/02/Imprimed.png)
Two new clinical studies indicate that ImpriMed's artificial intelligence (AI) algorithms have successfully identified chemotherapy drugs with prospective clinical efficacy in oncology practices throughout US - Connected-vet
![ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground](https://prunderground-production-public.s3.amazonaws.com/uploads/2021/01/ImpriMed-Medicine-Services-for-Canines--1024x682.jpeg)
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers | PRUndergroundPRUnderground
ImpriMed, Inc. on X: "We are at #PMWC24! Come by our booth #D1241 and learn how our Live Cell + AI Platform could assist in your novel drug development. We would love
![ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology - intelligence360 ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology - intelligence360](https://i0.wp.com/www.intelligence360.news/wp-content/uploads/2023/12/Imprimed.jpg?fit=1200%2C598&ssl=1)